BCR is classically associated with chronic myelogenous leukemia, in which it forms a fusion protein with tyrosine-protein kinase ABL1 (c-Abl) leading to aberrant kinase activity (Rowley, 1973). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.